Grey and White Matter Changes across the Amyotrophic Lateral Sclerosis-Frontotemporal Dementia Continuum

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Lillo, Patricia ^a,b   Mioshi, Eneida ^a,b   Burrell, James R ^a,b   Kiernan, Matthew C ^a,b   Hodges, John R ^a,b,c   Hornberger, Michael ^a,b,c  

^a NEUROSCIENCE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ARC CENTRE OF EXCELLENCE IN COGNITION AND ITS DISORDERS   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR CINGULATE; ARTICLE; BRAIN ATROPHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE MARKER; EDUCATIONAL STATUS; FEMALE; FRONTAL LOBE; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; FRONTOTEMPORAL DEMENTIA; GENDER; GRAY MATTER; HUMAN; MALE; MOTOR CORTEX; NERVE DEGENERATION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PYRAMIDAL TRACT; TEMPORAL LOBE; VOXEL BASED MORPHOMETRY; WHITE MATTER;

AMYOTROPHIC LATERAL SCLEROSIS; ATROPHY; BEHAVIOR; BRAIN; CASE-CONTROL STUDIES; COGNITION; DIFFUSION TENSOR IMAGING; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; MALE; MIDDLE AGED; MOTOR CORTEX; PREFRONTAL CORTEX; PYRAMIDAL TRACTS;

EID: 84865605482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043993     Document Type: Article

References (52)

1. Geser F, Brandmeir NJ, Kwong LK, Martinez-Lage M, Elman L, et al. (2008) Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis. Archives of Neurology 65: 636-641.
2. Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, et al. (2011) Amyotrophic lateral sclerosis. Lancet 377: 942-955.
3. Lomen-Hoerth C, Anderson T, Miller B, (2002) The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology 59: 1077-1079.
4. Ringholz GM, Appel SH, Bradshaw M, Cooke NA, Mosnik DM, et al. (2005) Prevalence and patterns of cognitive impairment in sporadic ALS. Neurology 65: 586-590.
5. Lillo P, Savage S, Mioshi E, Kiernan MC, Hodges JR, (2012) Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum. Amyotroph Lateral Scler 13: 102-109.
6. Strong MJ, Lomen-Hoerth C, Caselli RJ, Bigio EH, Yang W, (2003) Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Annals of Neurology 54: S20-S23.
7. Phukan J, Elamin M, Bede P, Jordan N, Gallagher L, et al. (2011) The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry.
8. Bak TH, Hodges JR (2001) Motor neurone disease, dementia and aphasia: coincidence, co-occurrence or continuum? Journal of Neurology 248: 260-+.
9. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
10. Kwong LK, Neumann M, Sampathu DM, Lee VMY, Trojanowski JQ, (2007) TDP-43 proteinopathy: the neuropathology underlying major forms of sporadic and familial frontotemporal lobar degeneration and motor neuron disease. Acta Neuropathologica 114: 63-70.
11. Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, et al. (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72: 257-268.
12. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, et al. (2011) Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72: 245-256.
13. Chio A, Borghero G, Restagno G, Mora G, Drepper C, et al. (2012) Clinical characteristics of patients with familial amyotrophic lateral sclerosis carrying the pathogenic GGGGCC hexanucleotide repeat expansion of C9ORF72. Brain 135: 784-793.
14. Byrne S, Elamin M, Bede P, Shatunov A, Walsh C, et al. (2012) Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study. Lancet Neurol 11: 232-240.
15. Cooper-Knock J, Hewitt C, Highley JR, Brockington A, Milano A, et al. (2012) Clinico-pathological features in amyotrophic lateral sclerosis with expansions in C9ORF72. Brain 135: 751-764.
16. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, et al. (2012) Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 135: 765-783.
17. Hsiung GY, DeJesus-Hernandez M, Feldman HH, Sengdy P, Bouchard-Kerr P, et al. (2012) Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p. Brain 135: 709-722.
18. Simon-Sanchez J, Dopper EG, Cohn-Hokke PE, Hukema RK, Nicolaou N, et al. (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain 135: 723-735.
19. Snowden JS, Rollinson S, Thompson JC, Harris JM, Stopford CL, et al. (2012) Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 135: 693-708.
20. Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, et al. (2012) Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 135: 736-750.
21. Turner MR, Grosskreutz J, Kassubek J, Abrahams S, Agosta F, et al. (2011) Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol 10: 400-403.
22. Mezzapesa DM, Ceccarelli A, Dicuonzo F, Carella A, De Caro MF, et al. (2007) Whole-brain and regional brain atrophy in amyotrophic lateral sclerosis. American Journal of Neuroradiology 28: 255-259.
23. Mori H, Yagishita A, Takeda T, Mizutani T, (2007) Symmetric temporal abnormalities on MR imaging in amyotrophic lateral sclerosis with dementia. American Journal of Neuroradiology 28: 1511-1516.
24. Chang JL, Lomen-Hoerth C, Murphy J, Henry RG, Kramer JH, et al. (2005) A voxel-based morphometry study of patterns of brain atrophy in ALS and ALS/FTLD. Neurology 65: 75-80.
25. Boxer AL, Mackenzie IR, Boeve BF, Baker M, Seeley WW, et al. (2011) Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family. J Neurol Neurosurg Psychiatry 82: 196-203.
26. Brooks BR, Miller RG, Swash M, Munsat TL, (2000) El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 1: 293-299.
27. Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, et al. (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain.
28. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR, (2006) The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21: 1078-1085.
29. Wedderburn C, Wear H, Brown J, Mason SJ, Barker RA, et al. (2008) The utility of the Cambridge Behavioural Inventory in neurodegenerative disease. J Neurol Neurosurg Psychiatry 79: 500-503.
30. Smith SM, (2002) Fast robust automated brain extraction. Hum Brain Mapp 17: 143-155.
31. Zhang Y, Brady M, Smith S, (2001) Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 20: 45-57.
32. Andersson JLR, Jenkinson M, Smith S (2007) Non-linear registration, aka Spatial normalisation.
33. Smith SM, Nichols TE, (2009) Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44: 83-98.
34. Nichols TE, Holmes AP, (2002) Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15: 1-25.
35. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, et al. (2006) Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
36. Andersson JLR, Jenkinson M, Smith S (2007) Non-linear optimisation.
37. Rabinovici GD, Seeley WW, Kim EJ, Gorno-Tempini ML, Rascovsky K, et al. (2007) Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration. Am J Alzheimers Dis Other Demen 22: 474-488.
38. Seeley WW, Crawford R, Rascovsky K, Kramer JH, Weiner M, et al. (2008) Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol 65: 249-255.
39. Burrell JR, Kiernan MC, Vucic S, Hodges JR, (2011) Motor neuron dysfunction in frontotemporal dementia. Brain 134: 2582-2594.
40. Chen Z, Ma L, (2010) Grey matter volume changes over the whole brain in amyotrophic lateral sclerosis: A voxel-wise meta-analysis of voxel based morphometry studies. Amyotroph Lateral Scler 11: 549-554.
41. Woolley SC, York MK, Moore DH, Strutt AM, Murphy J,et al. Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS). Amyotroph Lateral Scler 11: 303-311.
42. Tsujimoto M, Senda J, Ishihara T, Niimi Y, Kawai Y, et al. (2011) Behavioral changes in early ALS correlate with voxel-based morphometry and diffusion tensor imaging. J Neurol Sci.
43. Woolley SC, Zhang Y, Schuff N, Weiner MW, Katz JS, (2011) Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI. Amyotrophic Lateral Sclerosis 12: 52-58.
44. Geser F, Martinez-Lage M, Robinson J, Uryu K, Neumann M, et al. (2009) Clinical and Pathological Continuum of Multisystem TDP-43 Proteinopathies. Archives of Neurology 66: 180-189.
45. Whitwell JL, Jack CR, Senjem ML, Josephs KA, (2006) Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration. Neurology 66: 102-104.
46. Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, et al. (2010) Frontal-lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Eur J Neurol 17: 103-110.
47. Geser F, Lee VM, Trojanowski JQ, (2010) Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: a spectrum of TDP-43 proteinopathies. Neuropathology 30: 103-112.
48. Filippini N, Douaud G, Mackay CE, Knight S, Talbot K, et al. (2010) Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis. Neurology 75: 1645-1652.
49. Li J, Pan P, Song W, Huang R, Chen K, et al. (2011) A meta-analysis of diffusion tensor imaging studies in amyotrophic lateral sclerosis. Neurobiol Aging.
50. Rosen HJ, Allison SC, Schauer GF, Gorno-Tempini ML, Weiner MW, et al. (2005) Neuroanatomical correlates of behavioural disorders in dementia. Brain 128: 2612-2625.
51. Lillo P, Mioshi E, Zoing MC, Kiernan MC, Hodges JR, (2011) How common are behavioural changes in amyotrophic lateral sclerosis? Amyotroph Lateral Scler 12: 45-51.
52. Hodges J, (2012) Familial frontotemporal dementia and amyotrophic lateral sclerosis associated with the C9ORF72 hexanucleotide repeat. Brain 135: 652-655.